Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00795158Phase 3Completed
A Phase 3 trial of desloratadine in chronic urticaria (CU), sponsored by Organon & Co.. Started Nov 2002; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00795158.